In Phase II Clinical Trials
Development of Effective and Innovative Medicines to Address the needs of Patients and Improve their Health, Longevity and Quality of Life.
Hub Controls
  • Demo Video
  • Private Messages
  • Edit My Profile
  • View/Edit My Portfolio
Email Updates
Search
Message: NEWS - Zysolin(TM) Improves Survival in Pivotal Animal Studies
Reply New Message
« Prev Message Back To Forum Go to Threaded View Next Message »
Generic_profile
helloalpha
Rank: [?]
Mail Room
Points: [?]
96
Rating: [?]
Votes: 2 Score: 3.0
  • Currently 3.0/5 Stars.
Your Vote:
Please Log In to Vote
Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: NEWS - Zysolin(TM) Improves Survival in Pivotal Animal Studies

in response to Re: NEWS - Zysolin(TM) Improves Survival in Pivotal Animal Studies by Tutty
posted on Jun 27, 08 01:09PM

Finally, something good is about to happen!

Zysolin, first-in-class nanomedicine, this could be huge for ALRX, especially we can use the same nano technology for other products.

Reply New Message
« Prev Message Back To Forum Go to Threaded View Next Message »
New Message

Please login to post a reply

Subscribe to Rss Feed
Executive Address
Alrxsmall
Michael Lee
President
May 18, 2006

 

Michael Lee provides the investor community an update on recent events

View Broadcast

Stock Quote
Open alrx Stock Quote